Clinical Practice Guidelines for Pancreatic Cancer 2022 -revisions to surgical and adjuvant therapies-
-
- IKENAGA Naoki
- Department of Surgery and Oncology, Kyushu University
-
- IOKA Tatsuya
- Department of Oncology Center, Yamaguchi University Hospital
-
- EGUCHI Hidetoshi
- Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University
-
- OHTSUKA Takao
- Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University
-
- ONOE Shunsuke
- Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine
-
- KAWAI Manabu
- Second Department of Surgery, Wakayama Medical University
-
- SHO Masayuki
- Department of Surgery, Nara Medical University
-
- SUGIURA Teiichi
- Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center
-
- NAKATA Kohei
- Department of Surgery and Oncology, Kyushu University
-
- NAKAMURA Satoaki
- Division of Radiation Oncology, Kansai Medical University
-
- FUJII Tsutomu
- Department of Surgery and Science, Faculty of Medicine, Academic Assembly, University of Toyama
-
- MATSUMOTO Ippei
- Department of Surgery, Kindai University Faculty of Medicine
-
- MATSUYAMA Ryusei
- Department of Gastroenterological Surgery, Yokohama City University
-
- MIZUMA Masamichi
- Department of Surgery, Tohoku University
-
- YAMAMOTO Tomohisa
- Department of Surgery, Kansai Medical University
-
- NAKAMURA Masafumi
- Department of Surgery and Oncology, Kyushu University
Bibliographic Information
- Other Title
-
- 外科的治療法，補助療法
Description
<p>The Clinical Practice Guidelines for Pancreatic Cancer 2022 were newly revised in July 2022. Compared with the previous 2019 version, three clinical questions (CQs) were created, five CQs/statements were modified, and two CQs were abolished, resulting in 20 CQs inquiring about surgical and adjuvant therapies being established in the 2022 version. This article describes the revision to CQs and statements in surgical and adjuvant therapies of the Clinical Practice Guidelines for Pancreatic Cancer 2022.</p>
Journal
-
- Suizo
-
Suizo 38 (2), 115-120, 2023-04-28
Japan Pancreas Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390859073057884416
-
- ISSN
- 18812805
- 09130071
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- OpenAIRE
-
- Abstract License Flag
- Disallowed